Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab — from finance.yahoo.com by Laura Bratton

AI chipmaker Nvidia (NVDA) and pharmaceutical giant Eli Lilly (LLY) on Monday announced that the two companies would jointly invest $1 billion to create a lab in San Francisco focused on using AI to accelerate drug discovery.

The $1 billion investment will be spent over five years on infrastructure, compute, and talent for the lab. Nvidia’s engineers will work alongside Lilly’s experts in biology, science, and medicine to generate large-scale data and build AI models to advance medicine development. The lab’s work will begin early this year, the companies said.